SECOND–GENERATION EVEROLIMUS–ELUTING STENTS VERSUS FIRST–GENERATION DRUG–ELUTING STENTS FOR PATIENTS TREATED FOR MULTIVESSEL DISEASE

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Complete versus incomplete revascularization in patients with multivessel coronary artery disease treated with drug-eluting stents.

BACKGROUND The clinical impact of completeness of revascularization on adverse cardiovascular events remains unclear among patients with multivessel coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI). METHODS This analysis included consecutive patients with multivessel CAD, who underwent PCI with drug-eluting stents (DES) during the period from January 1, 2003, ...

متن کامل

Drug-eluting stents vs bypass surgery for multivessel disease.

To the Editor: We read with great interest the study by Yamagata et al of percutaneous coronary intervention (PCI) using sirolimuseluting stents vs off-pump coronary artery bypass grafting (CABG) in diabetic patients with multivessel disease (MVD).1 Despite a non-randomized retrospective analysis, however, any statistical adjustment (eg, propensity score analysis or Cox proportional hazards reg...

متن کامل

Everolimus Eluting Stents Versus Coronary Artery Bypass Graft Surgery for Patients With Diabetes Mellitus and Multivessel Disease.

BACKGROUND In patients with diabetes mellitus and multivessel disease, coronary artery bypass graft surgery and percutaneous coronary intervention are treatment options. However, there is paucity of data comparing coronary artery bypass graft surgery against newer generation stents. METHODS AND RESULTS Patients included in the New York State registries who had diabetes mellitus and underwent ...

متن کامل

Treating multivessel disease in the era of coated stents: conclusion.

T he worse long term outcome observed after percutaneous transluminal coronary angioplasty (PTCA) than after coronary artery bypass grafting (CABG) in patients at high risk of restenosis and disease progression such as diabetics, remind us that there is a substantial difference between treating a focal lesion with percutaneous coronary intervention and the use of arterial or vein grafts which b...

متن کامل

Treating multivessel disease in the era of coated stents: introduction.

Treating multivessel disease in the era of coated stents: introduction N umerous reports in cardiology congresses and journals deal with multivessel treatment with percutaneous transluminal coronary angioplasty (PTCA) and stenting. Clinical practice, however, is very different with more than 90% of all percutaneous revascularisation procedures in Europe and the USA limited to single vessel trea...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of the American College of Cardiology

سال: 2013

ISSN: 0735-1097

DOI: 10.1016/s0735-1097(13)61705-2